Pharmaceutical Technology

DECEMBER 14, 2022

Bacteria naturally develop resistance to antibiotics over time, through genetic mutation, horizontal gene transfer between bacteria, or because of selective pressure. Virus versus bacteria. Phages are viruses of bacteria. Secondly, the relationships between phages and bacteria are very specific.

Bacteria 130

Bacteria DNA Clinical Trials Clinical Trials 130

XTalks

JANUARY 19, 2021

But in the age of COVID-19, as consumers are understandably wary of microorganisms and their potential to make us sick, how can food brands find and effectively market the right bacteria? But with the global fermented ingredient market estimated to be worth over $35.5 billion by 2023 , the trend will likely outlast the pandemic.

Bacteria 52

Bacteria Branding Marketing Containment 52

XTalks

JULY 6, 2021

CDIs usually develop after treatments with antibiotics as they can kill off healthy bacteria in the gut in the process of targeting the pathogenic bacteria. Related: How Sugar May Impair Brain Development in Children. Firmicutes microbes are an important protective species in the gut and are also involved in the life cycle of C.

Marketing 105

Marketing Drugs Bacteria FDA Approval 105

Pharmaceutical Technology

FEBRUARY 26, 2023

The idea behind these treatments relies on altering the gut microbiome by designing therapeutics that contain bacteria derived from donated stool samples. Coupled with this, the harsh conditions of the biotech market affected some companies. This is further emphasised by the current state of the biotech market , he adds.

Bacteria 278

Bacteria Trials Research Medicine 278

Pharmaceutical Technology

MAY 25, 2023

The trial, conducted in 1,800 healthy individuals ranging from ages 2-29 years in Mali and The Gambia in 2021, found NmCV-5 induced a strong immune response across five strains of meningococcal bacteria. The response was more powerful than that generated by MenACWY-D – a licensed quadrivalent meningococcal vaccine marketed by GSK.

Vaccine 195

Vaccine Vaccination Immune Response Bacteria 195

Pharmaceutical Technology

SEPTEMBER 22, 2022

A late-stage asset of Spero, tebipenem HBr is being developed as the first oral carbapenem antibiotic to treat cUTIs, including pyelonephritis, which are caused by specific bacteria. Under the deal, GSK will obtain an exclusive licence for the development and marketing of tebipenem pivoxil HBr in all countries.

Bacteria 147

Bacteria Marketing Trials Clinical Development 147

Pharmaceutical Technology

OCTOBER 27, 2022

Antimicrobial resistance is when bacteria and viruses become resistant to medication, making previous treatments ineffective. “This can significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need such as the development of new antibiotics or rare and neglected diseases.”

Drugs 147

Drugs Big Data Bacteria Development 147

Scienmag

NOVEMBER 22, 2021

Now, a first-of-its-kind Stanford University analysis evaluates the market potential of the approach, in which bacteria fed captured methane grow into protein-rich fishmeal. Like a mirage on the horizon, an innovative process for converting a potent greenhouse gas into a food security solution has been stalled by economic uncertainty.

Bacteria 77

Bacteria Protein Research Marketing 77

XTalks

OCTOBER 29, 2024

Although UTIs are often straightforward to treat, they are commonly caused by strains of bacteria increasingly resistant to traditional antibiotics, such as amoxicillin and ciprofloxacin. uUTIs affect millions in the US each year and primarily affect women.

FDA Approval 105

FDA Approval Bacteria Clinical Trials Clinical Trials 105

Pharmaceutical Technology

MARCH 10, 2023

Pharmaceutical and biotechnology industries widely use freeze-drying systems to protect vaccines, antibodies, antibiotics such as penicillin, blood plasma, proteins, enzymes, hormones, viruses, and bacteria from heat and minimise their biological activity.

Manufacturing 147

Manufacturing Production Containment Antibody 147

Roots Analysis

OCTOBER 19, 2023

Bacteria plays a crucial role in maintaining the ecosystem balance. However, there are few species of bacteria that can cause several infectious diseases ( such as strep throat, salmonellosis, tuberculosis, whooping cough ). The overuse of antibiotics has resulted in the emergence of multi-drug-resistant bacteria.

Bacteria 40

Bacteria Production In-Vivo In-Vitro 40

Delveinsight

SEPTEMBER 29, 2021

Probiotics are a type of beneficial or live bacteria that provides various valuable benefits such as boosting the immune system and maintaining digestive health. Our body hosts natural bacteria (in the gut), and an imbalance in their occurrence can lead to a wide range of diseases and symptoms. Are Probiotics considered medicine?

Bacteria 78

Bacteria Manufacturing Marketing Production 78

XTalks

JULY 14, 2021

In this episode, Ayesha talks about Nestlé’s marketing of Seres Therapeutics’ oral microbiome drug for recurrent C. CDIs typically develop after the use of antibiotics, which can wipe out the gut’s healthy bacteria. Nestlé to Market Seres’ Oral Microbiome Drug for C. Difficile infection (CDI). Read the full articles here: .

Bacteria 52

Bacteria Marketing Drugs Containment 52

XTalks

OCTOBER 29, 2024

Although UTIs are often straightforward to treat, they are commonly caused by strains of bacteria increasingly resistant to traditional antibiotics, such as amoxicillin and ciprofloxacin. uUTIs affect millions in the US each year and primarily affect women.

FDA Approval 98

FDA Approval Bacteria Clinical Trials Clinical Trials 98

XTalks

NOVEMBER 28, 2023

Following passive diffusion into the organism, metronidazole is activated in the cytoplasm of susceptible anaerobic bacteria through reduction. The reduced form of metronidazole, along with free radicals, interacts with DNA, inhibiting DNA synthesis and causing DNA degradation, ultimately leading to the demise of the bacteria.

FDA Approval 103

FDA Approval Bacteria DNA Drugs 103

XTalks

MAY 4, 2022

In order to reach a critical mass of bacteria for testing, food samples must be incubated to allow bacteria to grow. According to Research and Markets, the global food safety testing market reached a value of $19.2 billion in 2021 and the market is expected to reach $33.4 It has also raised a total of $2.4

Bacteria 98

Bacteria Marketing Engineer Licensing 98

XTalks

NOVEMBER 24, 2021

Here’s how it works: methanotrophic bacteria , which serve as biofilters for the oxidation of methane, transform the greenhouse gas into protein-rich fishmeal for farmed fish. “In This is where methanotrophic bacteria come in.

Bacteria 98

Bacteria Production Protein Research 98

XTalks

OCTOBER 16, 2023

The Salt Lake County Health Department in Utah confirmed that 14 people have been infected with Campylobacter , a bacteria that causes foodborne illness from the consumption of raw or undercooked food. Coli bacteria. It also extends milk’s shelf life by decreasing spoilage bacteria.

Bacteria 104

Bacteria Sales Contamination Regulation 104

pharmaphorum

DECEMBER 4, 2020

Under the agreement Valneva could receive up to $308 million in cash payments, after Pfizer paid $130 million up front for marketing rights to the vaccine if it succeeds in the clinic. OspA is one of the most dominant surface proteins expressed by the bacteria when present in the ticks that spread the disease.

Vaccine 119

Vaccine Vaccination Bacterium Protein 119

pharmaphorum

JUNE 9, 2022

Matt Regan, the company’s CEO, explains how Micreos Pharmaceuticals’ technology and its fast evolving Drug Discovery and Drug Development capabilities can help bring novel therapies to market. Not to mention that traditional antibiotics are designed to attack a broad spectrum of bacteria within the host’s body.

Bacteria 104

Bacteria Development In-Vitro Drugs 104

XTalks

JULY 28, 2021

Merck has scored US Food and Drug Administration (FDA) approval for its next-generation pneumonia vaccine Vaxneuvance that covers 15 different strains of the pneumococcal bacteria that causes the infection. Both next-gen shots offer enhanced protection against bacteria that can cause pneumonia, blood infections and meningitis.

FDA Approval 89

FDA Approval Vaccine Vaccination Immune Response 89

Delveinsight

FEBRUARY 18, 2021

Like troops at the forefront of any battle, our immune system continually marches to protect us from foreign elements and invaders, including bacteria, viruses, and others. There is only a limited number of pharma companies that are working to develop therapies in the Hypofibrinogenemia market.

Marketing 52

Marketing Protein Bacteria Pharma Companies 52

BioPharma Reporter

OCTOBER 8, 2020

coli bacteria causing recurrent urinary tract infections (UTIs). Locus Biosciences has signed a contract with the Biomedical Advanced Research and Development Authority (BARDA), to co-fund development of LBP-EC01, a CRISPR Cas3-enhanced bacteriophage (crPhage) that targets E.

Bacteria 64

Bacteria Development Research Regulation 64

Druggist

JANUARY 4, 2021

Flucloxacillin is classified as narrow-spectrum antibiotics, which means it is effective against infections caused by a limited number of bacteria, particularly Staphylococcus aureus , which commonly cause bacterial skin infections. Broad-spectrum antibiotics, such as amoxicillin may offer treatment against a wider group of bacteria.

Bacteria 98

Bacteria Licensing Licensing Drugs 98

XTalks

JUNE 7, 2022

They are caused by bacteria, viruses, parasites or chemical substances entering the body through contaminated food or water. Food safety is a global issue that has become more complex in recent years due to globalization, the rise of antibiotic-resistant bacteria and the increase in food fraud. How to Get Involved .

Contamination 98

Contamination Bacteria Regulation Development 98

XTalks

MAY 31, 2024

The FDA’s decision was based on robust clinical data demonstrating Exblifep’s efficacy against antimicrobial resistance in gram-negative bacteria, particularly resistance associated with extended-spectrum beta-lactamases and ampC enzymes. What are cUTIs? However, Enterococcus spp. and Candida spp. The success rate was 79.1

Bacteria 52

Bacteria FDA Approval Trials Drugs 52

pharmaphorum

SEPTEMBER 28, 2021

VLA15 targets the outer surface protein A (OspA) of the Borrelia burgdorferi bacteria that causes Lyme disease, a tick-borne infection that causes a characteristic rash that can be accompanied by flu-like symptoms and – in some cases – debilitating tiredness and aches that can last for years.

Vaccine 105

Vaccine Vaccination Bacteria Protein 105

XTalks

AUGUST 28, 2020

To help address the continued need for personal protective equipment (PPE) in the current COVID-19 pandemic, a group of entrepreneurs and PPE specialists have developed a modular full-face mask called Blanc; it is being marketed by their new company that goes by the same name. This mask does not allow this to happen while wearing it.

Containment 111

Containment Bacteria Marketing Production 111

XTalks

MAY 16, 2022

Boochcraft became a pioneer in the now booming hard kombucha market as consumers began stepping away from hard seltzers in search for a healthier alternative. Typically made by mixing ingredients like yeast, bacteria, sugar and tea, kombucha is made by letting the mixture rest in a warm environment for a few weeks.

Branding 98

Branding Sales Bacteria Marketing 98

XTalks

DECEMBER 2, 2022

difficile as certain antibiotics can disrupt the balance of bacteria in the gut, allowing bacteria like C. Related: Nestlé to Market Seres’ Oral Microbiome Drug for C. While Rebyota is the first of its kind pharmaceutical therapy, the concept of healing the gut via fecal matter-derived bacteria is not new. Difficile. “As

FDA Approval 59

FDA Approval Bacteria Clinical Trials Clinical Trials 59

BioPharma Reporter

NOVEMBER 14, 2023

in seed funding to develop targeted therapeutics against antibiotic-resistant Gram-negative bacteria. Glox Therapeutics, a company developing precision antibiotic therapies based on naturally occurring bacteriocins, has raised Â4.3m

Development 52

Development Bacteria Regulation Marketing 52

XTalks

JANUARY 22, 2021

It identifies bacteria using both genotypic and phenotypic assessments within 1.5 Empirical treatment usually gives two to three antibiotics at the same time to suppress unknown bacteria.”. fAST: Automated Bacteria Identification and Multiple Antibiotics Combination Test.

Bacteria 52

Bacteria In-Vitro Genotype Marketing 52

XTalks

DECEMBER 23, 2024

billion doses through the Advance Market Commitment mechanism. Meanwhile, researchers advanced alternative therapies to combat antimicrobial resistance, targeting drug-resistant bacteria with novel antibiotics. AI-driven platforms also proved invaluable.

Vaccine 52

Vaccine Vaccination Containment Bacteria 52

Pharmaceutical Technology

JUNE 6, 2023

Pharma Mar Overview Pharma Mar discovers, develops and markets marine-derived drugs to treat cancer. Pharma Mar offers in vitro diagnostic products used for detection of virus and bacteria in respiratory infections and human papilloma virus genotypes, among others. It is administered through intravenous route.

Hormones 100

Hormones In-Vitro Genotype Bacteria 100

Druggist

OCTOBER 4, 2020

Lepicol has a rather unique formula of three different ingredients: Psyllium husk Live bacteria Insulin (a fibre from chicory root and not the Insulin produced by the pancreatic cells) As advertised the Insulin (chicory root) is not broken down by the body, but fermented by live bacteria to support the growth of natural bacterial flora in the gut.

Containment 98

Containment Pharmacy Bacteria Sales 98

XTalks

MAY 3, 2024

To combat food poisoning, US agriculture officials introduced a final rule last Friday, mandating significant reductions in Salmonella bacteria in specific chicken products. This question becomes crucial as the US Department of Agriculture (USDA) mandates lower Salmonella levels in certain frozen chicken items.

Regulation 103

Regulation Production Contamination Packaging 103

pharmaphorum

AUGUST 7, 2020

Biogen has bought a licence to co-develop and co-market potential Parkinson’s disease drugs with US biotech Denali, in a deal worth more than $2.1 Biogen and Denali will co-market the lead LRRK2 product in the US and China, and Biogen will commercialise in all other markets.

Bacteria 69

Bacteria Marketing Licensing Licensing 69